On December 23, 2021 Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, reported that the Company will participate in the Biotech Showcase 2022 Virtual Conference to be held January 10-12, 2022 (Press release, Cyclacel, DEC 23, 2021, View Source [SID1234597673]). Spiro Rombotis, President & Chief Executive Officer, will present an overview of Cyclacel’s business and the Company will be available for virtual meetings during the conference. In addition, Mr. Rombotis will participate in a Biotech Showcase Workshop, entitled, "Outsmarting Cancer: Next Generation Therapies".

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details can be found below:

Conference: virtual meetings and on-demand presentation (available January 3, 2022)
Date: January 10-12
Registration Link

Workshop: "Outsmarting Cancer: Next Generation Therapies"
Format: live broadcast
Date: January 10, 8:00am PT/11:00am ET
Registration Link
The presentation and archived webcast can be accessed for 90 days and can be found on the Cyclacel website at www.cyclacel.com.